PCM Encore’s CVS Health CVS Stock Holding History

PCM Encore’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$620K	Buy	5,997 +257	+4%	+$22.9K	0.11%	173
2026 Q1	$412K	Buy	5,740 +123	+2%	+$9.47K	0.08%	239
2025 Q4	$446K	Buy	+5,617	New	+$443K	0.09%	212

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

PCM Encore's CVS Position: Q2 2026 in Review

PCM Encore increased its CVS Health (CVS) stake by 4.5% in Q2 2026, buying an estimated $22.9K and bringing the position to 5,997 shares worth $620K. The position accounts for 0.11% of the portfolio, ranked #173.

PCM Encore first reported a position in CVS in Q4 2025 and has held it in 3 quarters since. 2,063 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

PCM Encore held 5,997 shares of CVS Health worth $620K as of Q2 2026.
PCM Encore bought 257 CVS Health shares in Q2 2026, an estimated $22.9K.
CVS Health made up 0.11% of PCM Encore's portfolio in Q2 2026, its #173 holding.
PCM Encore first reported a position in CVS Health in Q4 2025 and has held it in 3 quarters since.
2,063 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.